Machine learning prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis: a cross-cultural validation in Caucasian and Han Chinese cohort.

Authors:
Liu J; Chen X; Guo X; Xu R; Wang Y and 1 more

Journal:
Ther Adv Neurol Disord

Publication Year: 2022

DOI:
10.1177/17562864221129380

PMCID:
PMC9549180

PMID:
36225969

Journal Information

Full Title: Ther Adv Neurol Disord

Abbreviation: Ther Adv Neurol Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Xinyue Chen is an employee of Siemens Healthineers. She had no control on the study raw data. She declares no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: JL is supported by the National Natural Science Foundation of China (grant no. 81901199), the China Postdoctoral Science Foundation (grant no. 2018M643494), and the 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (grant no. ZYGD18009). ML is supported the Major International (Regional) Joint Research Project, National Natural Science Foundation of China (grant no. 81620108009), National Natural Science Foundation of China (grant no. 81974181), and the 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (grant no. ZYGD18009)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025